Our results showed that afatinib could significantly increase the clonogenic cell death in response to radiotherapy in established gefitinib-resistance human lung cancer cell PC-9-GR subline bearing EGFR 19Del/T790M double mutations in vitro, and enhance the tumor growth inhibition in xenografts model. The gene discussed is EGFR; the disease is lung cancer.